| OHSU # 3286 |
CD74 as a biomarker and therapeutic target for familial platelet (FPD) disorder |
Anupriya Agarwal, Mona Mohammadhosseini |
| OHSU # 3234 |
Combination therapy for the treatment of triple negative breast cancer |
Sanjay Malhotra, Lisa Coussens, Dhanir Tailor, Sushil Kumar, Arpit Dheeraj |
| OHSU # 3063 |
A method of enhancing cancer immunotherapies through androgen receptor modulation |
Fanny Polesso, Amy Moran |
| OHSU # 3024 |
Universal nanoprobes for imaging and treatment of cancer |
Adem Yildirim, Jared Fischer, Bruce Branchaud |
| OHSU # 3015 |
Covalent inhibitors of PARP-16 for cancer treatment |
Michael (Mike) Cohen, Daniel Bejan, Sunil Sundalam |
| OHSU # 3001 |
Anti-cancer compounds with improved cardiac safety and drug resistance profiles |
Mark Mercola, Sanjay Malhotra, Mallesh Pandrala, Dhanir Tailor, Arne Antoon Bruyneel |
| OHSU # 2757 |
Clickable, photoactivatable NAD+ analogues as probes for PARP and other NAD+-binding targets |
Sunil Sundalam, Michael (Mike) Cohen |
| OHSU # 2670 |
Inhibitors of cancer-mediated bone destruction |
Raymond Bergan, Ryan Gordon, Abhinandan Pattanayak |
| OHSU # 2648 |
Methods of treating venetoclax-resistant acute myeloid leukemia |
Jeffrey (Jeff) Tyner, Haijiao Zhang, Beth Wilmot, Daniel Bottomly, Shannon McWeeney, Stephen (Steve) Kurtz, Christopher (Chris) Eide, Ravindra Majeti |
| OHSU # 2561 |
Mutation-specific treatment strategies for acute myeloid leukemia |
Jeffrey (Jeff) Tyner, Cristina Tognon, Brian Druker, Daniel Bottomly, Beth Wilmot, Stephen (Steve) Kurtz, Samantha Savage Stevens, Nicola Long, Anna Reister Schultz, Elie Traer, Shannon McWeeney |
| OHSU # 2414 |
MicroRNA inhibitors to enhance radiotherapy efficacy |
Sudarshan Anand, Shushan Rana, Charles Thomas Jr |
| OHSU # 2413 |
A therapeutic approach to minimize residual disease and relapse in cancer |
George Thomas, Hui-wen Lue, Jennifer Podolak, Kevin Kolahi |
| OHSU # 2291 |
Radiation-enhanced delivery of antisense oligonucleotides against MGMT |
Prakash Ambady, Ying-Jen (Jeffrey) Wu, Edward Neuwelt |
| OHSU # 1699 |
Pharmaceutical compositions comprising napthamides |
Xiangshu Xiao |
| OHSU # 1295 |
Naphthamides as anticancer agents inhibiting CREB-mediated gene transcription |
Xiangshu Xiao, Bingbing Li |